FARALLON CAPITAL MANAGEMENT LLC Q2 2020 Filing

Filed August 14, 2020

Portfolio Value

$12.2T

Holdings

116

Report Date

Q2 2020

Filing Type

13F-HR

All Holdings (116 positions)

#StockSharesValue% PortfolioType
101
ATENTO S A
11,212,205$7.7B0.06%
102
AKOUOS INC
225,000$5.1B0.04%
103
APPLIED MOLECULAR TRANS INC
200,000$5.0B0.04%
104
RADIUS HEALTH INC
6,750,000$5.0B0.04%
105
INTERCEPT PHARMACEUTICALS IN
6,500,000$4.8B0.04%
106
RPTXREPARE THERAPEUTICS INC
150,000$4.7B0.04%
107
ARYA SCIENCES ACQUISTION CO
400,000$4.6B0.04%
108
FUSION PHARMACEUTICALS INC
250,000$4.4B0.04%
109
OPHTEURIVERIC BIO INC
750,000$3.8B0.03%
110
CTRIP COM INTL LTD
3,508,000$3.5B0.03%
111
DMTKQDERMTECH INC
194,675$2.6B0.02%
112
BROADMARK RLTY CAP INC
7,174,613$2.3B0.02%
113
RNAAVIDITY BIOSCIENCES INC
50,000$1.4B0.01%
114
GOSSGOSSAMER BIO INC
100,000$1.3B0.01%
115
CTMXCYTOMX THERAPEUTICS INC
148,952$1.2B0.01%
116
GOLGBPGOL LINHAS AEREAS INTELIGENT
85,838$582.0M0.00%
PreviousPage 2 of 2